Literature DB >> 27638415

Maternal Circulating microRNAs and Pre-Eclampsia: Challenges for Diagnostic Potential.

Malia S Q Murphy1, Chandrakant Tayade1, Graeme N Smith2,3.   

Abstract

Pre-eclampsia (PE) is a common hypertensive disorder of pregnancy with a significant impact on maternal and neonatal mortality and morbidity. While the pathogenesis of PE has been well described, identification of a biomarker(s) with robust predictive utility in identifying women at the highest risk of developing the condition has yet to be identified. In the search for diagnostic markers, those that may be obtained from the circulation are preferred alternatives to those derived from organ tissue samples. Because of their stability in plasma, microRNAs (miRNAs) have been explored as biomarkers in a host of disease states, although there is comparably little literature available on the circulating miRNAome of PE. This article provides a narrative review on the current state of knowledge on miRNAs associated with PE. Literature on circulating miRNAs is presented and the challenges to developing the diagnostic and prognostic utility of miRNAs in this context is discussed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27638415     DOI: 10.1007/s40291-016-0233-0

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  72 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia.

Authors:  Frank Noack; Julika Ribbat-Idel; Christoph Thorns; Andrea Chiriac; Roland Axt-Fliedner; Klaus Diedrich; Alfred C Feller
Journal:  J Perinat Med       Date:  2011-02-10       Impact factor: 1.901

Review 3.  Redefining preeclampsia using placenta-derived biomarkers.

Authors:  Anne Cathrine Staff; Samantha J Benton; Peter von Dadelszen; James M Roberts; Robert N Taylor; Robert W Powers; D Stephen Charnock-Jones; Christopher W G Redman
Journal:  Hypertension       Date:  2013-03-04       Impact factor: 10.190

4.  Differential miRNA expression profiles between the first and third trimester human placentas.

Authors:  Yang Gu; Jingxia Sun; Lynn J Groome; Yuping Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-26       Impact factor: 4.310

5.  Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies.

Authors:  Xiao-ming Zhu; Tao Han; Ian L Sargent; Guo-wu Yin; Yuan-qing Yao
Journal:  Am J Obstet Gynecol       Date:  2009-03-14       Impact factor: 8.661

6.  Potential role of circulating microRNAs as early markers of preeclampsia.

Authors:  Blendi Ura; Giordana Feriotto; Lorenzo Monasta; Sabrine Bilel; Marina Zweyer; Claudio Celeghini
Journal:  Taiwan J Obstet Gynecol       Date:  2014-06       Impact factor: 1.705

7.  Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas.

Authors:  L Guo; S Q Tsai; N E Hardison; A H James; A A Motsinger-Reif; B Thames; E A Stone; C Deng; J A Piedrahita
Journal:  Placenta       Date:  2013-04-30       Impact factor: 3.481

8.  Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes.

Authors:  B M Herrera; H E Lockstone; J M Taylor; M Ria; A Barrett; S Collins; P Kaisaki; K Argoud; C Fernandez; M E Travers; J P Grew; J C Randall; A L Gloyn; D Gauguier; M I McCarthy; C M Lindgren
Journal:  Diabetologia       Date:  2010-03-03       Impact factor: 10.122

9.  Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression.

Authors:  Yang Bai; Weiwei Yang; Hui-xia Yang; Qinping Liao; Gang Ye; Guodong Fu; Lei Ji; Peng Xu; Hao Wang; Yu-xia Li; Chun Peng; Yan-ling Wang
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

10.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

View more
  6 in total

1.  Cross-talk between miR-29c and transforming growth factor-β3 is mediated by an epigenetic mechanism in leiomyoma.

Authors:  Tsai-Der Chuang; Omid Khorram
Journal:  Fertil Steril       Date:  2019-12       Impact factor: 7.329

2.  miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.

Authors:  Quanbo Ji; Xiaojie Xu; Qi Song; Yameng Xu; Yanhong Tai; Stuart B Goodman; Wenzhi Bi; Meng Xu; Shunchang Jiao; William J Maloney; Yan Wang
Journal:  Mol Ther       Date:  2018-03-14       Impact factor: 11.454

Review 3.  A Data-Driven Review of the Genetic Factors of Pregnancy Complications.

Authors:  Yury A Barbitoff; Alexander A Tsarev; Elena S Vashukova; Evgeniia M Maksiutenko; Liudmila V Kovalenko; Larisa D Belotserkovtseva; Andrey S Glotov
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

Review 4.  Pregnancy-Related Extracellular Vesicles Revisited.

Authors:  Carmen Elena Condrat; Valentin Nicolae Varlas; Florentina Duică; Panagiotis Antoniadis; Cezara Alina Danila; Dragos Cretoiu; Nicolae Suciu; Sanda Maria Crețoiu; Silviu Cristian Voinea
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

5.  Circulating noncoding RNAs as early predictive biomarkers in preeclampsia: a diagnostic meta-analysis.

Authors:  Sha Su; Fang Yang; Linlin Zhong; Lihong Pang
Journal:  Reprod Biol Endocrinol       Date:  2021-12-01       Impact factor: 5.211

Review 6.  Noncoding RNAs in Unexplained Recurrent Spontaneous Abortions and Their Diagnostic Potential.

Authors:  Ningyi Jia; Jian Li
Journal:  Dis Markers       Date:  2019-12-04       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.